Financhill
Back

Alnylam Pharmaceuticals, Inc. 10K Form

Sell
30

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:
$326.86
Seasonality Move:
-0.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ALNY News And Ratings

See the #1 stock for the next 7 days that we like better than ALNY

ALNY Financial Statistics

Sales & Book Value

Annual Sales: $3.7B
Cash Flow: $140.3M
Price / Cash Flow: 91.4
Annual Sales: $5.96
Price / Book: 53.55

Profitability

EPS (TTM): 2.25710
Net Income (TTM): $313.7M
Gross Margin: $3B
Return on Equity: 107.73%
Return on Assets: 6.83%

Alnylam Pharmaceuticals, Inc. Earnings Forecast

Key Alnylam Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 21 years for ALNY is 81.64%.
  • The Selling, General & Administrative Expenses for ALNY have been equal to 32.60% of Gross Profit Margin.
  • The Research & Development expenses have been 35.54% of Revenue.
  • The Interest Expense is 80.52% of Operating Income.
  • The Net Earning history of ALNY is 8.45% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 12 years.

Alnylam Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALNY
CUSIP: 02043Q
Website: alnylam.com

Debt

Debt-to-Equity Ratio: 3.76
Current Ratio: 2.76
Quick Ratio: 2.51

Price-to-Earnings

Trailing P/E Ratio: 136.79
Forward P/E Ratio: 21.92

ALNY Technical Analysis vs Fundamental Analysis

Sell
30
Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. a Buy or a Sell?